This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Demyelinating diseases of the central nervous system
G6_DEMYEL
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
3749 |
6. Filter based on genotype QC (FinnGen only) |
3586 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Demyelinating diseases of the central nervous system
based on the number of shared cases.
Similar with more cases:
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3586 | 2641 | 945 |
| Unadjusted period prevalence (%) | 0.80 | 0.94 | 0.43 |
| Median age at first event (years) | 38.55 | 37.37 | 41.87 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3749
- Matched controls
- 37490
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G04BD12
ATC
mirabegron; oral
5.4
316.6
719
1577
N06BA07
ATC
modafinil; oral
44.4
312.9
186
44
N07XX09
ATC
[U] dimethyl fumarate
+∞
307.7
366
*
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
+∞
307.7
1748
*
L03AB08
ATC
interferon beta-1b; parenteral
+∞
307.7
417
*
L03AB07
ATC
interferon beta-1a; parenteral
+∞
307.7
964
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
18.8
307.7
1686
1561
2AB04, ,
NOMESCO Finland
213.1
307.7
258
13
109
Kela drug reimbursment
Multiple sclerosis
+∞
307.7
2165
*
G35
ICD-10 Finland
Multiple sclerosis
4503599627370496.0
307.7
3070
5
353
Kela drug reimbursment
Cladribine and fingolimod
+∞
307.7
468
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
9.6
307.7
406
467
TAB00
NOMESCO Finland
Lumbar puncture
23.6
307.7
1224
753
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
32.7
307.7
391
133
M03BX01
ATC
baclofen; systemic
26.5
307.7
550
242
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
16384.0
307.7
1197
*
XA800
NOMESCO Finland
Neuropsychological investigation
9.9
307.7
572
671
XKD06
NOMESCO Finland
Physiologic investigation of micturition
15.8
307.7
399
281
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
14.7
307.7
336
249
L04AA31
ATC
[U] teriflunomide
+∞
307.7
463
*
N86
ICPC
Multiple sclerosis
2122.6
307.7
941
6
164
Kela drug reimbursment
Fingolimod
+∞
307.7
521
*
H46
ICD-10 Finland
Optic neuritis
159.7
307.7
853
69
N04BB01
ATC
amantadine; oral
52.9
307.7
620
140
L04AX07
ATC
dimethyl fumarate; oral
+∞
307.7
605
*
L04AA27
ATC
[U] fingolimod
+∞
307.7
368
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
15.7
307.7
409
290
G04BD09
ATC
trospium; oral
16.1
307.7
314
212
R20.2
ICD-10 Finland
Paraesthesia of skin
6.0
307.7
764
1527
L03AX13
ATC
glatiramer acetate; parenteral
+∞
307.7
766
*
XCK00
NOMESCO Finland
Perimetry
7.6
307.7
524
780
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
+∞
307.7
1853
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.2
307.7
869
1749
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.2
302.5
723
1654
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
+∞
284.0
269
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
6.2
281.0
528
968
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
29.1
280.2
188
68
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
17.9
277.9
228
135
ZX120
NOMESCO Finland
Intravenous
4.8
257.3
668
1625
XKD00
NOMESCO Finland
Uroflowmetry
4.7
250.0
654
1599
G04BD04
ATC
oxybutynin; oral, transdermal
6.7
235.2
395
644
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.6
234.6
1010
3518
XKC03
NOMESCO Finland
Water cystometry
9.3
234.3
293
340
3400A
ICD-9 Finland
Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]
+∞
231.7
220
*
R1250
NOMESCO Finland
Evaluation of functional capability
9.5
224.1
273
306
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
+∞
222.1
211
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
8.8
213.9
279
341
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
10.6
204.8
229
228
N03AE01
ATC
clonazepam; systemic
5.2
203.0
451
955
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
16.9
202.4
170
105
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
23.5
200.6
145
64
H53.2
ICD-10 Finland
Diplopia
7.4
196.1
297
432
TKC22
NOMESCO Finland
Catheterisation instruction
12.4
196.0
197
167
L04AK02
ATC
teriflunomide; oral
+∞
188.1
179
*
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
20.0
182.4
141
73
UKC02
NOMESCO Finland
Cystoscopy
3.7
179.0
676
2131
L03AB13
ATC
peginterferon beta-1a; parenteral
+∞
178.6
170
*
N03AX12
ATC
[U] gabapentin; oral
3.1
176.4
916
3513
G04BD07
ATC
tolterodine; oral
6.3
173.5
308
528
34099
ICD-8 Finland
Multiple sclerosis
+∞
166.9
159
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.0
165.2
528
1480
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
12.8
163.3
160
130
G04BD08
ATC
solifenacin; oral
5.1
159.6
362
776
L04AG12
ATC
ofatumumab; parenteral
+∞
157.4
150
*
N28
ICPC
Limited function/disability (N)
11.4
154.2
163
149
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.4
153.0
413
1019
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
36.7
149.3
93
26
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
26.5
142.0
98
38
L04AE01
ATC
fingolimod; oral
+∞
141.6
135
*
4AA23, ,
NOMESCO Finland
1347.2
134.2
130
*
N29
ICPC
Neurological sympt/complt other
8.1
131.5
180
232
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
44.2
131.2
78
18
L04AA40
ATC
cladribine; oral
+∞
129.9
124
*
H02AB04
ATC
methylprednisolone; systemic
2.9
128.9
751
3020
R4150
NOMESCO Finland
Neuropsychological rehabilitation
12.5
122.9
122
101
XCD10
NOMESCO Finland
Electrophysiological examination of eye
7.5
122.3
180
252
H48.1*G35
ICD-10 Finland
Retrobulbar neuritis in multiple sclerosis
+∞
121.5
116
*
SPAT1229
SPAT
Assessment of need for aid
4.1
121.2
360
950
L04AA52
ATC
[U] ofatumumab; parenteral
+∞
119.4
114
*
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
+∞
119.4
114
*
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
7.8
118.7
167
222
L28
ICPC
Limited function/disability (L)
2.8
118.3
681
2712
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
31.4
118.2
77
25
R35
ICD-10 Finland
Polyuria
4.2
116.8
337
870
R33
ICD-10 Finland
Retention of urine
4.3
116.1
314
772
N99
ICPC
Neurological disease other
10.7
116.0
127
122
G04BD11
ATC
fesoterodine; oral
7.1
108.3
166
243
Z2445
NOMESCO Finland
Psychologist
4.2
107.5
299
750
H47.2
ICD-10 Finland
Optic atrophy
23.9
104.7
75
32
XKD03
NOMESCO Finland
Urethral pressure profilometry
6.9
102.4
161
242
G36.0
ICD-10 Finland
Neuromyelitis optica [Devic]
+∞
101.5
97
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.1
100.4
472
1671
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
10.6
100.4
111
108
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
5.4
99.7
204
397
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
18.5
97.7
78
43
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.3
96.5
264
653
N03AX16
ATC
[U] pregabalin
2.3
96.5
1007
5246
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
11.8
95.7
98
85
TKC20
NOMESCO Finland
Catheterisation of bladder
3.9
95.3
301
827
J01EA01
ATC
trimethoprim; systemic
2.1
91.4
1167
6562
L04AX01
ATC
azathioprine; systemic
3.9
91.2
283
767
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
9.1
89.3
110
124
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
13.7
88.8
83
62
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
23.3
85.8
62
27
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
9.6
84.4
100
107
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.7
83.0
197
435
Z3226
NOMESCO Finland
Physiotherapist
2.3
82.1
771
3812
Z3231
NOMESCO Finland
Registered nurse
2.1
82.0
1083
6126
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.0
81.5
394
1411
C10AC01
ATC
colestyramine; oral
4.9
80.9
185
396
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.4
80.4
655
3044
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
14.0
80.2
74
54
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.7
79.9
263
742
R4120
NOMESCO Finland
Occupational therapy
3.2
78.4
344
1164
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.4
77.6
628
2907
H53.1
ICD-10 Finland
Subjective visual disturbances
3.0
77.0
363
1280
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
5.4
77.0
155
297
SPAT1231
SPAT
Assessment of adjustments needed in living environment
7.7
76.4
108
144
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.1
76.4
350
1214
N03AF01
ATC
carbamazepine; oral, rectal
3.6
74.1
254
736
L89
ICD-10 Finland
Decubitus ulcer and pressure area
8.2
70.9
95
119
N02BF01
ATC
gabapentin; oral
2.7
70.5
411
1623
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.8
69.6
375
1421
N05CF01
ATC
zopiclone; oral
1.9
69.5
1189
7288
A28
ICPC
Limited function/disability NOS
2.5
69.3
479
2056
G37.2
ICD-10 Finland
Central pontine myelinolysis
+∞
66.9
64
*
R4110
NOMESCO Finland
Physiotherapy
1.9
64.7
1041
6224
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
13.2
63.1
60
46
3419X
ICD-9 Finland
Other demyelinating diseases of central nervous system, Demyelinating disease of central nervous system, unspecified
+∞
62.7
60
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
62.2
1028
6189
RF120, ,
NOMESCO Finland
7.2
61.0
91
129
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
10.0
60.5
69
70
G37.8
ICD-10 Finland
Other specified demyelinating diseases of central nervous system
+∞
59.5
57
*
N06AX16
ATC
venlafaxine; oral
2.0
57.5
712
3868
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.6
57.2
352
1423
36703
ICD-8 Finland
Inflammation of optic nerve and retina, Neuritis optica, retrobulbaris
124.0
57.0
61
5
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
5.9
55.8
101
175
R5110, ,
SPAT
3.0
55.3
251
863
CS494
NOMESCO Finland
Other visual field testing
4.7
54.5
129
284
Z43.5
ICD-10 Finland
Attention to cystostomy
16.9
54.0
45
27
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
12.8
53.8
52
41
G81.9
ICD-10 Finland
Hemiplegia, unspecified
7.1
53.4
81
117
SPAT1216
SPAT
Assessment of functional ability
2.3
53.1
474
2265
N04BD01
ATC
selegiline; oral
7.2
51.3
76
107
R42
ICD-10 Finland
Dizziness and giddiness
1.9
51.2
795
4648
AA1AD
NOMESCO Finland
CT of head and brain
1.9
51.1
826
4892
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
50.6
444
2105
G50.0
ICD-10 Finland
Trigeminal neuralgia
4.8
50.5
116
249
L01BB04
ATC
cladribine; systemic
+∞
50.1
48
*
G82.2
ICD-10 Finland
Paraplegia, unspecified
11.4
50.0
52
46
H53.4
ICD-10 Finland
Visual field defects
5.0
49.7
108
221
A06AD11
ATC
lactulose; oral
2.2
49.1
443
2123
3773B
ICD-9 Finland
Disorders of optic nerve and visual pathways, Optic neuritis[NEURITIS RETROBULBARIS]
484.0
48.5
48
*
J01XX05
ATC
methenamine; oral
8.5
48.1
62
74
N03AF02
ATC
oxcarbazepine; oral
3.4
47.2
173
522
U13
ICPC
Bladder symptom/complaint other
3.8
46.3
147
403
R20.1
ICD-10 Finland
Hypoaesthesia of skin
8.3
46.2
61
75
4AA36, ,
NOMESCO Finland
+∞
45.9
44
*
N06AA09
ATC
amitriptyline; systemic
2.3
45.5
367
1675
U04
ICPC
Incontinence urine
3.1
45.4
193
638
6BA02, ,
NOMESCO Finland
13.7
45.1
42
31
34109
ICD-8 Finland
Other demyelinating diseases of central nervous system, Unspecified
+∞
44.9
43
*
L04AX09
ATC
diroximel fumarate; oral
+∞
44.9
43
*
N30.0
ICD-10 Finland
Acute cystitis
1.9
44.8
662
3792
SPAT1167
SPAT
Insertion of urinary catheter
4.9
44.7
100
210
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.6
44.1
107
240
J01CA08
ATC
pivmecillinam; oral
1.6
43.8
1700
12709
R39.1
ICD-10 Finland
Other difficulties with micturition
4.0
43.8
127
327
U07
ICPC
Urine symptom/complaint other
2.5
43.5
278
1142
H02AB07
ATC
prednisone; oral
2.0
42.7
506
2684
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
42.6
421
2087
N18
ICPC
Paralysis/weakness
5.1
42.3
90
181
N04BC05
ATC
pramipexole; oral
2.5
42.1
277
1153
N06AX21
ATC
duloxetine; oral
2.0
41.8
528
2863
G04CA02
ATC
tamsulosin; oral
2.1
41.4
456
2354
G04BD10
ATC
darifenacin; oral
9.7
40.4
47
49
H51.2
ICD-10 Finland
Internuclear ophthalmoplegia
66.4
40.1
46
7
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
40.0
415
2093
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.7
39.6
227
883
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.6
39.5
238
949
119
Kela drug reimbursment
Trigeminal neuralgia or glossofaryngeusneuralgia
12.3
39.3
39
32
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.7
38.8
126
351
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.9
37.8
188
679
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
37.3
1363
9932
U05
ICPC
Urination problems other
3.0
37.0
167
571
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
36.7
467
2532
R27.0
ICD-10 Finland
Ataxia, unspecified
14.5
36.5
33
23
359
Kela drug reimbursment
Mirabegroni
11.3
36.2
38
34
RS221, ,
NOMESCO Finland
4.7
36.2
84
182
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
6.2
35.7
61
100
U28
ICPC
Limited function/disability (U)
7.6
35.2
50
67
A02BC02
ATC
pantoprazole; systemic
1.6
34.8
2380
19814
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
33.9
282
1300
M03BX02
ATC
tizanidine; oral
1.5
33.9
2425
20326
N30.9
ICD-10 Finland
Cystitis, unspecified
2.4
33.8
246
1071
Z2446
NOMESCO Finland
Social worker
2.3
33.4
270
1230
N07AA02
ATC
pyridostigmine; systemic
8.7
33.1
42
49
U08
ICPC
Urinary retention
5.6
33.0
63
115
R32
ICD-10 Finland
Unspecified urinary incontinence
3.7
32.9
105
289
RF420, ,
NOMESCO Finland
4.6
32.7
78
173
G61.0
ICD-10 Finland
Guillain-Barré syndrome
9.6
32.4
38
40
R15
ICD-10 Finland
Faecal incontinence
3.5
31.3
111
328
N02BF02
ATC
pregabalin; oral
2.3
31.3
250
1133
Z50.1
ICD-10 Finland
Other physical therapy
2.5
31.1
200
822
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.4
31.1
77
176
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.0
30.5
338
1741
G04BD01
ATC
emepronium; systemic
7.2
30.5
45
63
R20.0
ICD-10 Finland
Anaesthesia of skin
5.6
30.2
57
103
H57.1
ICD-10 Finland
Ocular pain
2.6
29.7
183
737
NA1CM
NOMESCO Finland
Cervical spine extensive MRI examination with 3 Tesla magnet
10.7
29.6
32
30
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
29.5
702
4565
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
29.3
410
2286
N06AB04
ATC
citalopram; systemic
1.6
29.0
770
5145
N87
ICPC
Parkinsonism
5.9
28.7
51
87
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
9.0
28.6
35
39
RF410, ,
NOMESCO Finland
4.7
28.5
66
143
RS222, ,
NOMESCO Finland
4.9
28.3
62
128
J01MA02
ATC
ciprofloxacin; systemic
1.5
27.4
1217
9105
G04BE03
ATC
sildenafil; oral
5.1
27.3
57
113
G36.8
ICD-10 Finland
Other specified acute disseminated demyelination
+∞
27.1
26
*
G70.0
ICD-10 Finland
Myasthenia gravis
9.0
26.8
33
37
U29
ICPC
Urinary symptom/complaint other
3.1
26.4
111
365
G97.1
ICD-10 Finland
Other reaction to spinal and lumbar puncture
10.4
26.2
29
28
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.4
26.0
184
790
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
25.6
783
5392
RS121, ,
NOMESCO Finland
6.1
25.4
44
73
WW400
NOMESCO Finland
Plasmaferesis
28.6
25.4
34
12
G37.0
ICD-10 Finland
Diffuse sclerosis
+∞
25.0
24
*
J01XE01
ATC
nitrofurantoin; oral
3.6
25.0
84
240
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.4
24.8
91
275
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
24.6
807
5641
XCK10
NOMESCO Finland
Photography of fundus of eye
2.0
24.3
263
1341
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.8
23.9
121
441
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.1
23.9
103
344
H30.2
ICD-10 Finland
Posterior cyclitis
8.6
23.6
30
35
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
23.4
343
1938
F02.89
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without information of additional symptoms
54.4
23.0
27
5
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
6.9
22.9
35
51
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
22.7
929
6785
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.5
22.7
79
231
R03CA02
ATC
ephedrine; oral
26.0
22.6
31
12
Z2221
NOMESCO Finland
Medical doctor
1.5
22.4
985
7295
ZXY02
NOMESCO Finland
Neuropsychologist
5.7
22.4
41
72
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
4.9
22.3
48
98
K59.09
ICD-10 Finland
Constipation, unspecified
2.2
22.1
192
900
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.5
21.8
74
213
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.5
21.7
136
553
ABD40
NOMESCO Finland
Implantation of spinal injection device
80.6
21.7
24
*
Z93.5
ICD-10 Finland
Cystostomy status
22.3
21.7
31
14
R60.0
ICD-10 Finland
Localized oedema
1.8
21.6
342
1976
G51.0
ICD-10 Finland
Bell palsy
2.8
21.6
108
392
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.3
21.6
80
244
R51.80
ICD-10 Finland
Headache
1.6
21.3
625
4245
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
21.2
880
6434
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
4.6
21.0
49
107
S97
ICPC
Chronic ulcer skin
2.3
20.9
156
687
H48.1
ICD-10 Finland
Retrobulbar neuritis in diseases classified elsewhere
+∞
20.8
20
*
M05BA04
ATC
alendronic acid; oral
2.1
20.7
201
985
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
5.3
20.6
41
78
G04CA01
ATC
alfuzosin; oral
2.0
20.4
240
1260
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
5.9
20.4
36
61
G04BDXX, ,
ATC
20.1
20.3
30
15
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
20.2
397
2439
RS130, ,
NOMESCO Finland
8.4
20.1
26
31
G04BE01
ATC
alprostadil; parenteral, urethral
4.9
20.1
44
91
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.6
20.1
121
483
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
19.9
332
1947
34108
ICD-8 Finland
Other demyelinating diseases of central nervous system, Alii definiti
+∞
19.8
19
*
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.2
19.8
164
755
RF432, ,
NOMESCO Finland
105.6
19.6
21
*
J01MA12
ATC
levofloxacin; systemic
1.6
19.5
514
3400
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
19.4
400
2487
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
19.3
393
2437
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.0
19.1
228
1204
N06
ICPC
Sensation disturbance other
3.9
19.0
55
142
G20
ICD-10 Finland
Parkinson disease
3.3
19.0
72
223
Z73.6
ICD-10 Finland
Limitation of activities due to disability
5.2
18.9
38
73
R47.1
ICD-10 Finland
Dysarthria and anarthria
5.0
18.7
40
81
H53.9
ICD-10 Finland
Visual disturbance, unspecified
2.4
18.7
134
579
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
7.0
18.6
28
40
N06AX11
ATC
mirtazapine; oral
1.4
18.6
1148
8989
J01MA06
ATC
norfloxacin; oral
1.6
18.4
431
2769
R13
ICD-10 Finland
Dysphagia
2.0
18.2
210
1095
N07AA03
ATC
distigmine; systemic
17.6
18.2
28
16
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
3.7
18.2
57
156
SPAT1262
SPAT
Handing over of treatment supplies
1.6
18.1
467
3072
N03AX09
ATC
lamotrigine; oral
1.9
18.0
220
1170
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
17.9
1224
9735
H02AB06
ATC
prednisolone; systemic
1.4
17.8
1544
12748
G37.1
ICD-10 Finland
Central demyelination of corpus callosum
+∞
17.7
17
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.1
17.6
170
831
C03CA01
ATC
furosemide; systemic
1.5
17.5
567
3922
36702
ICD-8 Finland
Inflammation of optic nerve and retina, Neuritis optica. Papillitis
180.8
17.5
18
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
17.5
225
1217
RS340, ,
NOMESCO Finland
12.6
17.1
30
24
U02
ICPC
Urinary frequency/urgency
1.6
17.0
454
3007
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
17.0
316
1911
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
16.5
264
1529
3773A
ICD-9 Finland
Disorders of optic nerve and visual pathways, Optic neuritis[PAPILLITIS OPTICA]
170.7
16.5
17
*
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
4.2
16.5
43
103
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.1
16.4
160
786
K59.0
ICD-10 Finland
Constipation
2.1
16.3
163
807
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
2.9
16.3
74
255
J05AB11
ATC
valaciclovir; oral
1.5
16.3
489
3324
G04.8
ICD-10 Finland
Other encephalitis, myelitis and encephalomyelitis
24.6
16.0
22
9
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
2.9
15.6
73
256
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.9
15.5
196
1055
U71
ICPC
Cystitis/urinary infection other
1.8
15.4
227
1282
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
4.5
15.4
37
83
G95.9
ICD-10 Finland
Disease of spinal cord, unspecified
16.1
15.2
24
15
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.2
15.2
132
620
N02BE01
ATC
paracetamol; systemic, rectal
1.4
15.1
3142
29291
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
4.2
15.1
40
97
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
2.8
15.0
74
267
N03AX14
ATC
levetiracetam; systemic
2.5
14.9
92
373
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
14.8
1082
8640
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
14.8
270
1624
N05BA01
ATC
diazepam; systemic, rectal
1.6
14.7
398
2640
NA7CM
NOMESCO Finland
Spine and spinal cord extensive MRI examination with 3 Tesla magnet
25.1
14.7
20
8
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
3.2
14.5
56
176
N02AX02
ATC
tramadol; systemic, rectal
1.3
14.4
1293
10639
SPAT1234
SPAT
Support of social functional capacity
2.1
14.4
130
621
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
14.3
467
3231
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
2.7
14.0
75
283
RF310, ,
NOMESCO Finland
6.7
14.0
22
33
R5599
NOMESCO Finland
Other rehabilitation service
2.4
14.0
95
402
NA1BM
NOMESCO Finland
Cervical spine MRI examination with 3 Tesla magnet
10.9
14.0
26
24
SPAT1263
SPAT
Sampling
1.3
14.0
1365
11353
R5130, ,
SPAT
15.8
13.9
22
14
XA402
NOMESCO Finland
ENMG
2.4
13.9
92
385
H50.52
ICD-10 Finland
Exophoria
3.1
13.9
57
186
3AX01, ,
NOMESCO Finland
6.0
13.8
24
40
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.3
13.6
102
451
SPAT1301
SPAT
No procedures
1.4
13.6
897
7036
RF122, ,
NOMESCO Finland
16.2
13.4
21
13
J01MA01
ATC
ofloxacin; systemic
1.8
13.4
223
1306
G96.9
ICD-10 Finland
Disorder of central nervous system, unspecified
18.3
13.4
20
11
WX892
NOMESCO Finland
Monitored bed care
1.8
13.3
196
1107
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
13.3
490
3470
R26.0
ICD-10 Finland
Ataxic gait
13.8
13.2
22
16
OAB43, ,
SPAT
0.7
13.1
910
11299
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.0
13.1
144
740
SPAT1325
SPAT
Vaccination
1.4
13.0
881
6931
N06AB10
ATC
escitalopram; oral
1.4
13.0
788
6092
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
3.3
13.0
48
147
G04BD
ATC
Drugs for urinary frequency and incontinence
13.0
12.9
22
17
R4110, ,
SPAT
1.7
12.9
245
1490
A02BA02
ATC
ranitidine; systemic
1.5
12.8
502
3597
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
12.7
575
4230
G61.8
ICD-10 Finland
Other inflammatory polyneuropathies
15.5
12.6
20
13
R31
ICD-10 Finland
Unspecified haematuria
1.7
12.6
209
1224
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
5.5
12.6
24
44
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
32.1
12.6
16
5
G36.1
ICD-10 Finland
Acute and subacute haemorrhagic leukoencephalitis [Hurst]
+∞
12.5
12
*
N07AB01
ATC
carbachol; systemic
11.0
12.5
23
21
1DB07, ,
NOMESCO Finland
130.4
12.4
13
*
G61.9
ICD-10 Finland
Inflammatory polyneuropathy, unspecified
11.6
12.3
22
19
SPAT1260
SPAT
Consultation of another employee
1.4
12.2
504
3643
T83.0
ICD-10 Finland
Mechanical complication of urinary (indwelling) catheter
37.7
12.2
15
*
XKX00
NOMESCO Finland
Pelvic floor electromyography
6.0
12.1
21
35
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
4.8
12.1
27
57
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
12.1
331
2200
R52.2
ICD-10 Finland
Other chronic pain
2.0
12.1
128
649
A41.9
ICD-10 Finland
Sepsis, unspecified
2.3
12.0
85
367
R4130
NOMESCO Finland
Speech therapy
2.5
12.0
75
306
SPAT1254
SPAT
Administration of medicine
1.5
12.0
372
2543
OAB50, ,
SPAT
1.9
11.9
150
807
R53
ICD-10 Finland
Malaise and fatigue
1.4
11.9
783
6124
ZY010
NOMESCO Finland
Hospital outpatient
1.7
11.8
195
1140
H47.1
ICD-10 Finland
Papilloedema, unspecified
4.2
11.8
31
75
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
2.6
11.7
68
268
108
Kela drug reimbursment
Myasthenia gravis
9.6
11.7
23
24
H52.1
ICD-10 Finland
Myopia
1.9
11.6
147
793
ZXA10
NOMESCO Finland
Bilateral
1.4
11.5
482
3492
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
9.2
11.5
23
25
RS230, ,
NOMESCO Finland
4.7
11.4
26
56
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.0
11.4
123
629
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.5
11.4
70
284
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
11.4
1373
11658
G72.9
ICD-10 Finland
Myopathy, unspecified
4.1
11.3
30
73
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
2.8
11.3
55
198
R50.9
ICD-10 Finland
Fever, unspecified
1.5
11.3
439
3137
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
3.9
11.3
32
82
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.5
11.0
371
2579
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
5.4
10.9
21
39
G83.1
ICD-10 Finland
Monoplegia of lower limb
9.6
10.7
21
22
AAH30
NOMESCO Finland
Thermal destruction of cranial nerve
28.1
10.7
14
5
R30.1
ICD-10 Finland
Vesical tenesmus
2.5
10.6
63
252
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.8
10.5
50
178
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
10.5
325
2219
XF600
NOMESCO Finland
Bloodpressure measurement
1.8
10.5
166
961
F05
ICPC
Visual disturbance other
2.2
10.4
86
398
D21
ICPC
Swallowing problem
2.9
10.3
46
158
J05AB01
ATC
aciclovir; systemic
1.3
10.3
712
5599
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
4.4
10.3
25
57
J01DB01
ATC
cefalexin; oral
1.3
10.2
2936
27505
TKC10, ,
SPAT
23.4
10.2
14
6
A46
ICD-10 Finland
Erysipelas
1.5
10.2
328
2258
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.1
10.2
41
133
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.7
10.1
204
1260
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
5.3
10.1
20
38
N27
ICPC
Fear of neurological disease other
3.0
10.1
43
144
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
10.1
348
2429
SPAT1255
SPAT
Intravenous administration of medicine
1.7
10.0
177
1056
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.0
10.0
100
498
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.6
10.0
210
1313
M48.0
ICD-10 Finland
Spinal stenosis
1.6
9.9
249
1623
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.5
9.9
61
248
RF210, ,
NOMESCO Finland
2.1
9.9
95
466
RF312, ,
NOMESCO Finland
16.7
9.9
15
9
183
Kela drug reimbursment
Lamotrigin and topiramate
3.2
9.9
38
120
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.7
9.8
195
1201
N02AA05
ATC
oxycodone; systemic
1.5
9.8
369
2619
Z01.2
ICD-10 Finland
Dental examination
1.2
9.8
1591
13916
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.3
9.8
73
324
78050
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Vertigo
4.0
9.8
27
68
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.2
9.7
38
121
SPAT1172
SPAT
Guidance concerning hydration
2.8
9.7
46
164
A29
ICPC
General symptom/complaint other
1.5
9.7
326
2265
OAA80, ,
SPAT
0.6
9.7
137
2345
G04.0
ICD-10 Finland
Acute disseminated encephalitis
55.1
9.6
11
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
9.6
529
4012
SPAT1281
SPAT
Other administrative function
1.6
9.6
226
1452
W19
ICD-10 Finland
Unspecified fall
1.6
9.6
254
1678
R1260
NOMESCO Finland
Evaluation of communicative skills
2.8
9.5
45
160
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.7
9.5
48
177
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
2.2
9.4
75
342
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
3.0
9.4
40
134
SPAT1171
SPAT
Bladder puncture
30.1
9.4
12
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.2
9.4
76
349
G11.9
ICD-10 Finland
Hereditary ataxia, unspecified
17.6
9.4
14
8
XA412
NOMESCO Finland
VEP
17.6
9.4
14
8
G37.5
ICD-10 Finland
Concentric sclerosis [Baló]
+∞
9.4
9
*
3418X
ICD-9 Finland
Other demyelinating diseases of central nervous system
+∞
9.4
9
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.3
9.4
753
6037
U01
ICPC
Dysuria/painful urination
1.6
9.4
243
1597
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
9.3
248
3658
34400
ICD-8 Finland
Other cerebral paralysis, Hemiplegia NUD
21.7
9.3
13
6
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
2.6
9.3
52
202
S28
ICPC
Limited function/disability (S)
4.7
9.3
21
45
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
4.7
9.3
21
45
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
3.6
9.3
29
80
H54.7
ICD-10 Finland
Unspecified visual loss
4.1
9.2
25
62
R25.2
ICD-10 Finland
Cramp and spasm
2.2
9.2
74
339
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.0
9.2
96
486
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
9.2
1142
9670
KCV04
NOMESCO Finland
Distension of bladder with fluid
3.5
9.2
31
90
K07
ICPC
Swollen ankles/oedema
2.0
9.2
93
466
N21.0
ICD-10 Finland
Calculus in bladder
4.2
9.2
24
58
R20.8
ICD-10 Finland
Other and unspecified disturbances of skin sensation
2.8
9.1
45
164
N30
ICD-10 Finland
Cystitis
1.5
9.1
272
1845
K59.01
ICD-10 Finland
Constipation outlet obstruction type
2.8
9.0
43
154
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
2.6
9.0
49
188
N04BC04
ATC
ropinirole; oral
3.7
9.0
28
77
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.3
9.0
68
304
ZXD05
NOMESCO Finland
Urgent procedure
1.3
9.0
986
8223
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
2.4
8.9
57
236
G04AA01, ,
ATC
3.8
8.9
26
68
N05BA04
ATC
oxazepam; oral
1.3
8.9
807
6569
SPAT1211
SPAT
Application of soft bandage
1.6
8.9
225
1470
N05CD07
ATC
temazepam; oral
1.5
8.9
239
1583
H20.1
ICD-10 Finland
Chronic iridocyclitis
3.0
8.9
38
128
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.4
8.8
61
262
R4120, ,
SPAT
3.5
8.8
29
83
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.8
8.8
125
702
RS142, ,
NOMESCO Finland
7.2
8.7
20
28
D12
ICPC
Constipation
2.0
8.7
85
421
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
8.6
872
7192
H81.4
ICD-10 Finland
Vertigo of central origin
3.7
8.6
26
70
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
4.6
8.6
20
44
M05BX04
ATC
denosumab; parenteral
1.8
8.5
119
664
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.9
8.5
101
535
M54.1
ICD-10 Finland
Radiculopathy
1.8
8.5
124
702
Z74.0
ICD-10 Finland
Need for assistance due to reduced mobility
27.6
8.5
11
*
Z50.5
ICD-10 Finland
Speech therapy
2.9
8.5
39
137
SPAT1127
SPAT
Enema
6.4
8.5
21
33
QBG10
NOMESCO Finland
Excision and repair of bedsore of trunk
20.1
8.5
12
6
R2110
NOMESCO Finland
Giving the first information
1.5
8.4
236
1580
RF214, ,
NOMESCO Finland
12.8
8.4
14
11
N19
ICPC
Speech disorder
3.2
8.3
32
101
A07AA09
ATC
vancomycin; oral
3.0
8.3
36
122
4AA34, ,
NOMESCO Finland
+∞
8.3
8
*
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
10.8
8.3
15
14
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
1.9
8.1
104
566
A06AC51
ATC
ispaghula, combinations; oral
1.7
8.1
130
757
L29
ICPC
Musculoskeletal sympt/complt other
1.5
8.1
239
1618
WX110
NOMESCO Finland
Infiltration anesthesia
1.2
8.0
2526
23477
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
8.0
403
3011
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
2.7
8.0
41
153
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
7.9
555
4362
RF433, ,
NOMESCO Finland
13.0
7.9
13
10
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
2.9
7.8
35
121
NA1DG
NOMESCO Finland
Cervical spine very extensive MRI examination with high intensity magnet
6.1
7.8
20
33
A02BA04
ATC
nizatidine; systemic
1.6
7.8
167
1050
J01DA01
ATC
[U] cefalexin
1.2
7.8
2081
18994
R83.4
ICD-10 Finland
Abnormal findings in cerebrospinal fluid, Abnormal immunological findings
45.1
7.7
9
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.7
7.7
127
746
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.6
7.7
42
162
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
7.7
2603
24312
E87.6
ICD-10 Finland
Hypokalaemia
2.0
7.7
84
434
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
3.4
7.7
26
76
U99
ICPC
Urinary disease other
4.0
7.6
21
53
R30.0
ICD-10 Finland
Dysuria
1.7
7.6
133
794
A02BC01
ATC
omeprazole; systemic
1.3
7.6
747
6131
A04
ICPC
Weakness/tiredness general
1.4
7.6
420
3185
N30.8
ICD-10 Finland
Other cystitis
2.9
7.6
34
118
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
11.9
7.6
13
11
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.1
7.6
65
307
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.2
7.6
1917
17384
E0000UV, ,
ATC
1.2
7.5
1337
11708
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
3.8
7.5
22
58
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.2
7.5
1235
10731
H53.8
ICD-10 Finland
Other visual disturbances
2.5
7.5
44
176
R20
ICD-10 Finland
Disturbances of skin sensation
4.2
7.5
19
45
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
4.2
7.5
19
45
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
3.1
7.4
30
98
N06AX12
ATC
bupropion; oral
1.4
7.4
275
1947
J01AA02
ATC
doxycycline; systemic
1.2
7.4
2602
24336
NA7DM
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with 3 Tesla magnet
13.4
7.4
12
9
5AB01, ,
NOMESCO Finland
7.6
7.4
16
21
SPAT1360
SPAT
Extensive global examination
1.6
7.4
171
1097
RF220, ,
NOMESCO Finland
2.7
7.3
38
143
H01AA02
ATC
tetracosactide; parenteral
+∞
7.3
7
*
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
3.6
7.3
23
64
G04BE08
ATC
tadalafil; oral
9.4
7.3
14
15
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
7.3
1190
10328
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.3
7.2
51
222
N32.0
ICD-10 Finland
Bladder-neck obstruction
6.2
7.2
18
29
NA1AG
NOMESCO Finland
Restricted MRI of cervical spine
15.8
7.2
11
7
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.0
7.2
73
367
H25.8
ICD-10 Finland
Other senile cataract
1.6
7.2
154
969
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
1.9
7.2
81
423
S06.0
ICD-10 Finland
Concussion
1.4
7.2
303
2197
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
2.2
7.2
54
242
N06AA10
ATC
nortriptyline; systemic
2.0
7.1
71
355
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.8
7.1
108
621
KDV20
NOMESCO Finland
Submucous urethral injection
12.0
7.1
12
10
R11
ICD-10 Finland
Nausea and vomiting
1.5
7.1
246
1722
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
2.8
7.1
34
123
W10
ICD-10 Finland
Fall on and from stairs and steps
1.6
7.0
139
858
G04AC01, ,
ATC
1.9
7.0
85
455
S72.4
ICD-10 Finland
Fracture of lower end of femur
3.6
7.0
22
61
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
7.0
1638
14702
SPAT1050
SPAT
Extensive neurological examination
2.2
7.0
56
258
K91
ICPC
Cerebrovascular disease
3.0
7.0
30
102
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.5
6.9
193
1291
RF311, ,
NOMESCO Finland
13.8
6.9
11
8
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
6.9
3331
32129
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
6.8
370
2795
WVA20
NOMESCO Finland
Medicine administration
2.0
6.8
70
354
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
6.8
2423
22577
L17
ICPC
Foot/toe symptom/complaint
1.2
6.8
803
6725
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.8
6.8
88
482
J96.1
ICD-10 Finland
Chronic respiratory failure
2.6
6.8
38
149
D64.9
ICD-10 Finland
Anaemia, unspecified
1.5
6.8
198
1339
A420_, ,
NOMESCO Finland
40.1
6.8
8
*
G12.2
ICD-10 Finland
Motor neuron disease
4.3
6.7
17
40
J02AC01
ATC
fluconazole; systemic
1.2
6.7
1467
13064
H51.8
ICD-10 Finland
Other specified disorders of binocular movement
16.7
6.7
10
6
JDB10
NOMESCO Finland
Percutaneous gastrostomy
3.1
6.7
27
88
L19
ICPC
Muscle symptom/complaint NOS
1.9
6.7
84
455
N86
ICD-10 Finland
Erosion and ectropion of cervix uteri
3.9
6.7
19
49
D17
ICPC
Incontinence of bowel
3.4
6.7
23
68
U72
ICPC
Urethritis
2.0
6.7
72
371
QBG00
NOMESCO Finland
Debridement of bedsore of trunk
22.5
6.7
9
*
S01.0
ICD-10 Finland
Open wound of scalp
1.5
6.6
171
1127
S42.2
ICD-10 Finland
Fracture of upper end of humerus
1.7
6.6
105
613
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.4
6.6
241
1705
G44.2
ICD-10 Finland
Tension-type headache
1.3
6.5
459
3604
G50.1
ICD-10 Finland
Atypical facial pain
2.1
6.5
58
279
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
6.5
353
2671
KH1EE
NOMESCO Finland
Urologic ultrasound examination
6.2
6.5
16
26
R5599, ,
SPAT
5.3
6.4
18
34
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.7
6.4
100
579
SPAT1125
SPAT
Stoma care and guidance
2.7
6.4
32
118
Z99.9
ICD-10 Finland
Dependence on unspecified enabling machine and device
70.0
6.4
7
*
34999
ICD-8 Finland
Other diseases of spinal cord, Other and unspecified
70.0
6.4
7
*
R60.9
ICD-10 Finland
Oedema, unspecified
1.6
6.4
128
793
A02BC03
ATC
lansoprazole; oral
1.2
6.4
770
6457
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
6.4
281
2054
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.0
6.4
64
322
SFA20
NOMESCO Finland
Two-surface restoration
1.2
6.4
2086
19234
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
2.4
6.3
40
166
SDA04
NOMESCO Finland
Demanding periodontal treatment
1.2
6.3
921
7879
G83.9
ICD-10 Finland
Paralytic syndrome, unspecified
6.5
6.3
15
23
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.1
6.3
53
249
R52.9
ICD-10 Finland
Pain, unspecified
1.4
6.3
269
1955
D82
ICPC
Teeth/gum disease
1.2
6.3
1279
11302
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
6.3
277
2026
G04BE09
ATC
vardenafil; oral
18.0
6.3
9
5
Z46.6
ICD-10 Finland
Fitting and adjustment of urinary device
18.0
6.3
9
5
R1250, ,
SPAT
2.2
6.3
47
211
G37.4
ICD-10 Finland
Subacute necrotizing myelitis
+∞
6.2
6
*
H47
ICD-10 Finland
Other disorders of optic [2nd] nerve and visual pathways
+∞
6.2
6
*
N03AX11
ATC
topiramate; oral
1.8
6.2
95
547
ZXE00
NOMESCO Finland
One hour or less
1.2
6.2
1208
10624
34409
ICD-8 Finland
Other cerebral paralysis, Unspecified
26.7
6.2
8
*
RF531, ,
NOMESCO Finland
26.7
6.2
8
*
78161
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Paraesthesia
26.7
6.2
8
*
R52.1
ICD-10 Finland
Chronic intractable pain
2.6
6.2
34
132
Z71.8
ICD-10 Finland
Other specified counselling
1.2
6.2
1012
8755
RS122, ,
NOMESCO Finland
4.0
6.2
17
43
NG1AA, ,
SPAT
0.6
6.2
102
1672
K02.1
ICD-10 Finland
Caries of dentine
1.2
6.1
2101
19414
TKD00
NOMESCO Finland
Dilatation of urethra
2.9
6.1
27
93
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
5.3
6.1
17
32
A08
ICPC
Swelling
1.7
6.1
110
663
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
6.1
1312
11640
N06AX18
ATC
reboxetine; oral
2.4
6.1
40
169
R93.0
ICD-10 Finland
Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
7.7
6.1
13
17
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.2
6.1
1006
8708
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.2
6.1
749
6292
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
3.0
6.1
25
83
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
6.1
612
5029
Z10.0
ICD-10 Finland
Occupational health examination
0.7
6.1
166
2433
SPAT1312
SPAT
General health counselling
1.2
6.1
946
8146
SPAT1104
SPAT
Monitoring of emergency patient
1.5
6.0
156
1029
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
2576
13768
3.78
317.89
12.4
5.9
0.75
0.68
%
10.07
2523
12910
2797
15824
4.02
315.06
12.8
6.0
0.19
0.19
e9/l
0.16
2602
14155
843
2134
4.81
312.77
1.3
1.3
35.12
48.67
au/ml
0.45
13
119
879
2317
4.65
309.75
2.5
2.4
30.49
22.65
au/ml
0.69
30
230
2780
15765
3.95
309.58
12.7
5.8
1.70
1.97
e9/l
10.43
2598
14219
2623
14356
3.75
307.91
12.6
6.2
9.00
8.18
%
42.31
2571
13545
717
237
37.17
307.65
1.1
1.1
215.66
236.27
mg/l
1.10
633
205
750
504
18.35
307.65
1.2
1.1
—
—
—
0
0
2769
15254
4.12
307.65
12.8
5.8
0.04
0.04
e9/l
0.30
2568
13408
493
178
31.74
307.65
1.1
1.1
0.99
1.04
u/l
0.90
194
81
2770
15227
4.14
307.65
12.7
5.8
0.55
0.55
e9/l
0.57
2568
13406
788
1753
5.43
307.65
3.5
1.7
1.08
1.39
g/l
4.06
773
1627
687
662
12.48
307.65
1.2
1.4
487.59
6959.65
e6/l
0.60
554
529
663
672
11.77
307.65
1.1
1.3
3.55
3.69
mmol/l
2.21
620
629
369
185
22.01
307.65
4.1
2.0
469.55
598.64
e6/l
1.47
320
149
1246
2260
7.76
307.65
3.4
2.6
10.01
10.56
g/l
5.15
1137
2083
687
662
12.48
307.65
1.2
1.4
30.41
26.35
e6/l
0.08
534
498
820
752
13.68
307.65
1.2
1.3
423.55
505.68
mg/l
3.84
792
710
227
17
142.07
307.65
1.1
1.0
—
—
—
0
0
402
28
160.70
307.65
1.2
1.1
—
—
—
0
0
483
13
426.34
307.65
2.8
1.1
—
—
—
0
0
625
300
24.80
307.65
1.1
1.1
—
—
—
0
0
655
1006
7.68
307.65
1.8
1.5
52.23
0.39
iu/ml
0.59
47
205
368
179
22.69
307.65
4.1
2.0
0.25
0.21
e9/l
2.31
323
149
2717
14307
4.27
307.65
13.0
6.2
—
—
—
0
0
276
164
18.09
307.65
1.1
1.1
1666.48
1523.70
miu/ml
0.71
276
164
732
231
39.13
307.65
1.1
1.1
—
—
—
0
0
732
249
36.29
307.65
1.1
1.2
53.17
33.64
mg/l
10.23
598
210
2611
14265
3.74
306.97
12.4
5.9
2.99
2.79
%
4.77
2560
13428
278
204
14.64
302.86
2.9
1.9
—
—
—
0
0
202
77
27.67
295.82
3.1
1.7
52.89
173.50
e6/l
3.95
90
40
2643
14891
3.63
288.25
12.4
5.9
26.50
29.19
%
34.35
2592
14086
2612
14698
3.56
283.43
12.1
5.7
58.76
56.55
%
20.33
2558
13895
191
72
27.90
280.69
4.7
2.5
—
—
—
0
0
2846
17487
3.61
255.03
13.8
8.8
3.75
4.01
e9/l
9.95
2641
15410
250
230
11.57
236.33
1.1
1.3
1.67
2.00
mmol/l
4.10
235
211
1653
8009
2.90
214.43
4.8
2.9
20.97
95.34
e6/l
3.31
1400
6046
2201
12535
2.83
207.20
2.5
2.2
89.37
74.53
nmol/l
72.49
2067
11592
1290
5554
3.02
206.56
3.5
2.4
4.92
7.08
e6/l
8.49
1208
4972
1535
7294
2.87
204.41
4.5
2.8
0.17
0.33
e6/l
6.98
1283
5444
1809
9781
2.64
181.23
5.8
3.4
75.48
77.24
e6/l
0.04
1450
6628
173
147
12.29
171.73
1.1
1.3
95.42
66.62
%
2.80
24
16
2851
19609
2.90
169.55
8.2
3.8
2574.05
1534.24
e6/l
0.28
39
228
2157
13530
2.40
145.73
13.7
8.4
0.00
0.00
e9/l
0.13
1868
11105
121
83
15.03
136.04
1.1
1.2
3.24
15.10
%
—
21
10
442
1305
3.71
126.98
1.4
2.1
36.35
39.52
u/l
2.91
416
1199
934
4351
2.53
118.51
4.1
2.5
0.92
1.18
e6/l
1.02
560
2366
1823
11382
2.17
114.72
4.1
4.7
37.18
36.45
g/l
6.82
1713
10656
2196
14917
2.14
108.87
5.9
3.3
0.00
0.00
estimate
0.03
542
2959
2214
15087
2.14
108.84
5.9
3.3
0.00
0.00
estimate
1.32
531
2769
2198
14964
2.13
107.95
7.8
4.5
0.00
0.00
estimate
0.37
533
2857
141
177
8.24
105.13
4.0
2.7
50.25
44.14
%
3.08
108
93
843
4073
2.38
96.38
4.4
2.6
4.94
3.44
e6/l
1.92
469
2098
548
2171
2.79
94.72
5.5
4.1
0.27
0.67
%
7.44
144
637
554
2267
2.69
89.62
5.8
4.3
0.04
0.12
%
1.96
134
626
106
139
7.82
76.10
1.2
1.7
—
—
—
0
0
95
114
8.52
73.39
1.1
1.1
108.09
461.62
ng/l
0.86
33
21
82
84
9.96
71.44
2.0
2.1
—
—
—
0
0
745
3829
2.18
71.15
1.9
2.2
29.23
29.44
s
0.67
715
3704
2014
14542
1.83
69.89
5.4
5.9
9.79
10.56
umol/l
4.06
1932
13797
421
1741
2.60
65.66
1.6
2.5
68.35
67.06
g/l
3.08
397
1608
104
159
6.70
65.03
1.1
1.1
—
—
—
0
0
209
583
3.74
64.35
4.2
3.8
60.33
56.88
%
3.80
209
583
1094
6813
1.86
59.03
2.4
1.4
2.05
2.24
g/l
4.78
825
4378
1203
7738
1.82
58.29
2.3
2.1
146.94
210.24
u/l
2.03
1148
7329
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
100
167
6.12
57.36
1.1
1.1
—
—
—
0
0
2129
16220
1.72
55.99
4.6
4.4
6.21
6.48
mmol/l
10.01
2009
14940
363
1524
2.53
54.50
2.6
1.7
—
—
—
0
0
56
55
10.32
50.22
1.1
1.3
—
—
—
0
0
2694
22369
1.73
47.30
7.0
7.1
74.12
74.54
u/l
0.22
2548
21212
447
2206
2.17
45.88
2.6
2.2
2374.27
5301.44
u/l
1.38
114
899
1155
7837
1.68
43.70
7.1
3.5
0.00
0.00
estimate
1.49
529
2806
114
272
4.29
43.49
1.2
1.6
—
—
—
0
0
290
1243
2.44
41.36
1.3
1.3
—
—
—
0
0
1580
11748
1.60
40.65
6.6
3.3
—
—
—
0
0
59
84
7.12
39.39
1.1
1.1
—
—
—
0
0
59
84
7.12
39.39
1.1
1.1
—
—
—
0
0
64
108
6.01
36.35
1.0
1.0
—
—
—
0
0
57
87
6.64
35.70
1.1
1.1
—
—
—
0
0
3434
31471
2.08
34.40
15.4
11.5
20.50
20.49
mg/l
0.00
2692
24492
1488
11220
1.54
34.18
8.7
10.4
1.11
1.15
inr
1.62
492
3459
94
240
3.99
32.80
1.2
1.6
—
—
—
0
0
57
98
5.89
31.78
1.1
1.2
—
—
—
0
0
1655
12909
1.50
31.64
6.3
6.2
1.22
1.21
mmol/l
2.64
1363
11041
3377
31001
1.90
30.16
15.1
12.1
139.64
139.65
mmol/l
0.13
3312
30215
51
83
6.22
30.05
1.1
1.1
—
—
—
0
0
2619
22574
1.53
30.04
4.4
2.9
43.24
40.72
u/l
0.76
2514
21478
52
87
6.05
29.81
1.1
1.1
—
—
—
0
0
3565
33404
2.37
29.64
15.5
9.1
26.61
26.22
u/l
0.64
3491
32475
3383
31119
1.89
29.36
15.2
12.2
3.91
3.93
mmol/l
3.76
3309
30265
264
1276
2.15
28.18
4.9
2.5
0.24
0.26
e6/l
0.08
257
1228
3093
27870
1.63
27.40
21.5
13.7
14.30
14.62
%
1.06
3058
27390
1370
10506
1.48
27.25
4.0
3.2
29.70
31.39
u/l
0.97
1326
10021
1001
7219
1.53
26.74
4.1
3.7
96.63
95.39
%
1.00
979
7022
1363
10473
1.47
26.69
1.9
1.8
95.63
98.00
pmol/l
1.06
708
5609
1477
11584
1.45
25.74
5.8
5.6
1.22
1.21
mmol/l
1.30
1337
10672
594
3831
1.65
25.45
1.9
1.8
—
—
—
0
0
2584
22635
1.46
23.80
3.7
3.9
10.33
10.22
mm/h
0.17
2415
21250
198
928
2.20
22.82
1.6
1.6
83.75
424.44
titre
1.86
12
36
115
427
2.75
21.99
1.3
1.8
—
1200.00
—
0
14
31
42
7.43
21.62
1.1
1.0
—
—
—
0
0
2842
30820
0.68
21.22
3.8
3.8
1.49
1.49
mmol/l
0.04
2618
29158
30
42
7.19
20.34
1.1
1.0
—
—
—
0
0
3174
29259
1.55
20.29
13.5
10.1
93.44
88.64
ml/min/173m2
35.18
2723
24153
51
121
4.26
19.72
1.1
1.2
—
—
—
0
0
80
262
3.10
19.22
1.1
1.2
—
—
—
0
0
28
39
7.23
19.07
1.1
1.1
91.39
43.75
%
4.00
18
16
2909
31287
0.69
18.92
4.0
4.1
2.86
2.89
mmol/l
1.19
2675
29535
2874
30968
0.69
18.73
3.8
3.8
4.76
4.81
mmol/l
1.64
2669
29402
2736
29704
0.71
18.21
3.4
3.5
1.26
1.27
mmol/l
0.42
2523
27980
251
1407
1.84
17.48
1.2
1.3
4.37
0.86
u/ml
0.68
11
122
763
5614
1.45
17.32
1.6
1.5
20.28
20.75
nmol/l
0.25
668
4923
24
32
7.54
16.96
1.0
1.1
—
—
—
0
0
395
2557
1.61
16.28
1.7
1.7
—
—
—
0
0
160
803
2.04
15.48
1.5
2.1
—
—
—
0
0
160
803
2.04
15.48
1.6
2.1
6.99
7.30
g/l
1.59
148
742
591
4228
1.47
15.36
1.7
1.7
1084.15
1180.89
nmol/l
1.51
452
3279
154
765
2.06
15.32
1.5
2.1
2.74
2.92
g/l
1.45
142
704
159
802
2.03
15.18
1.6
2.1
3.39
3.60
g/l
1.66
147
742
148
728
2.08
15.12
1.6
2.1
10.11
10.29
g/l
0.16
136
665
61
199
3.10
14.83
1.0
1.1
3.99
5.98
nmol/l
0.21
11
33
393
2604
1.57
14.63
1.8
1.7
—
—
—
0
0
163
841
1.98
14.61
1.5
2.1
9.17
11.12
mg/l
2.56
156
786
3134
29267
1.43
14.37
5.3
4.8
1.73
2.02
mu/l
2.06
2933
27521
1177
9555
1.34
14.35
3.2
2.9
33.43
39.33
ng/l
0.27
684
5160
25
43
5.85
13.98
1.0
1.2
—
—
—
0
0
833
6435
1.38
13.94
6.4
3.5
1.02
1.02
kg/l
0.16
119
931
217
1264
1.76
13.32
1.6
1.6
—
—
—
0
0
127
629
2.05
12.79
1.6
2.0
39.43
38.25
g/l
1.22
115
568
186
1053
1.81
12.58
1.8
1.9
1.18
1.18
g/l
0.02
179
991
181
1019
1.82
12.47
1.8
1.9
0.23
0.23
g/l
0.31
174
958
117
572
2.08
12.22
1.6
2.1
0.00
0.00
g/l
-0.00
108
533
188
1081
1.78
12.08
2.1
1.9
—
—
—
0
0
124
623
2.02
12.03
1.6
2.1
0.00
0.01
g/l
0.65
115
581
116
570
2.07
11.96
1.6
2.1
0.00
0.00
g/l
-0.00
108
532
83
359
2.34
11.71
3.0
3.2
0.55
1.48
%
5.25
78
328
132
688
1.95
11.56
1.6
2.2
0.48
0.77
g/l
0.55
119
616
109
532
2.08
11.45
1.5
1.7
0.58
0.73
g/l
1.00
79
409
26
58
4.51
10.94
1.1
1.2
—
—
—
0
0
163
929
1.79
10.82
2.0
1.8
—
—
—
0
0
1096
9095
1.29
10.72
2.6
3.2
2.35
2.35
mmol/l
0.26
954
8230
14
5
28.09
10.72
1.1
1.0
—
—
—
0
0
32
91
3.54
9.76
3.2
2.7
23.44
29.99
umol/l
1.77
22
67
170
1018
1.70
9.52
1.2
1.2
—
—
—
0
0
1068
8956
1.27
9.36
2.4
2.5
52.22
57.65
u/l
5.13
990
8345
152
892
1.73
9.17
1.3
1.3
108.89
176.86
titre
0.44
18
86
20
42
4.78
9.05
1.1
1.2
—
—
—
0
0
21
46
4.59
9.05
1.6
1.9
—
—
—
0
0
54
217
2.51
9.03
2.9
3.0
49.96
54.08
%
0.67
48
193
270
3887
0.67
9.00
1.6
1.6
—
—
—
0
0
50
198
2.55
8.63
1.3
1.1
1.63
29.39
u/ml
—
8
18
26
71
3.68
8.44
1.0
1.1
—
—
—
0
0
295
2065
1.47
8.43
3.9
3.5
1.23
1.23
mmol/l
0.32
255
1794
162
997
1.65
8.23
1.3
1.3
54.49
43.33
u/ml
—
10
69
94
494
1.93
8.14
1.3
1.3
—
—
—
0
0
94
494
1.93
8.14
1.3
1.3
—
—
—
0
0
20
32
6.28
8.00
1.1
1.2
—
—
—
0
0
134
795
1.71
7.82
1.9
2.3
234.49
339.08
ug/l
0.67
125
726
533
4169
1.32
7.82
3.3
3.5
0.82
0.82
mmol/l
0.15
494
3940
442
3363
1.36
7.81
2.8
2.7
6.23
7.24
umol/l
0.74
386
2897
22
57
3.88
7.69
1.1
1.2
—
—
—
0
0
17
24
7.11
7.47
1.1
1.0
—
—
—
0
0
354
2619
1.39
7.45
3.0
4.3
225.91
240.30
u/l
1.29
335
2488
350
2588
1.39
7.39
3.7
2.8
—
—
—
0
0
162
1030
1.60
7.26
2.2
1.9
—
—
—
0
0
334
2460
1.39
7.22
3.3
2.7
1.61
1.77
%
3.06
290
2196
36
134
2.70
7.08
1.1
1.2
—
—
—
0
0
228
1582
1.47
6.85
1.2
1.3
201.13
227.00
miu/ml
0.49
83
812
255
1816
1.43
6.69
1.8
1.6
—
—
—
0
0
15
22
6.84
6.50
1.1
1.0
—
—
—
0
0
684
5657
1.26
6.43
1.6
1.6
15332649.35
34391524.51
pmol/l
0.56
587
4853
25
80
3.14
6.43
1.2
1.1
88.92
97.31
%
0.62
25
80
143
910
1.59
6.42
1.3
1.3
3.56
7.55
u/ml
1.17
18
139
3623
35506
1.61
6.42
27.1
17.0
40.52
40.49
%
0.06
3440
33786
2673
25250
1.20
6.04
4.4
4.1
14.71
14.46
pmol/l
6.06
2462
23558
242
1748
1.41
5.89
2.6
2.7
64.53
72.56
e9/l
3.10
177
1300
139
898
1.57
5.88
1.3
1.3
2.67
6.77
u/ml
—
9
94
107
652
1.66
5.75
2.3
3.0
—
—
—
0
0
3625
35581
1.57
5.74
27.0
17.0
6.51
6.66
e9/l
3.18
3573
34809
124
786
1.60
5.70
1.3
1.3
52.05
36.69
u/ml
0.44
13
75
78
436
1.81
5.69
1.4
1.5
—
—
—
0
0
3622
35551
1.56
5.66
27.0
17.0
263.69
261.17
e9/l
1.62
3580
34850
577
4747
1.25
5.64
3.0
3.2
336.52
468.69
ng/l
0.45
331
3044
24
82
2.94
5.56
1.2
1.4
102.56
125.72
nmol/l
0.38
16
63
3624
35583
1.55
5.56
27.0
16.9
4.51
4.53
e12/l
1.23
3576
34823
16
42
3.82
5.53
1.8
2.0
—
—
—
0
0
14
24
5.85
5.52
1.1
1.0
4.83
21.60
%
—
6
5
3624
35592
1.55
5.44
27.1
17.0
135.62
135.77
g/l
0.29
3599
35220
14
25
5.62
5.36
1.5
1.6
1.53
0.76
mg/l
—
8
15
401
3175
1.29
5.35
5.0
5.8
1.00
1.03
mmol/l
1.98
367
2968
188
1338
1.43
5.02
4.6
3.0
132.72
130.71
g/l
0.69
183
1305
116
751
1.56
4.93
1.7
1.6
—
—
—
0
0
11
17
6.49
4.77
3.4
5.6
—
—
—
0
0
92
572
1.62
4.65
1.2
1.3
3.09
4.29
u/ml
0.61
33
242
29
121
2.41
4.63
1.3
1.7
9.76
13.20
u/l
2.75
29
116
67
386
1.75
4.50
2.0
2.3
—
—
—
0
0
195
1426
1.39
4.49
4.2
3.2
5.19
5.14
kpa
0.45
187
1371
108
705
1.55
4.46
1.3
1.3
1.08
3.24
u/ml
—
8
51
57
315
1.82
4.40
1.3
1.5
—
—
—
0
0
187
1365
1.39
4.36
4.2
3.2
1.95
1.57
mmol/l
0.89
158
1014
132
909
1.47
4.25
5.0
6.1
1.87
1.69
%
0.74
123
844
814
7121
1.18
4.21
1.7
1.8
0.84
0.95
mg/l
0.97
587
5284
121
821
1.49
4.19
1.9
2.1
2.06
1.66
ug/l
0.15
97
740
12
25
4.81
4.18
1.4
1.6
1.03
0.40
mg/l
—
5
13
12
25
4.81
4.18
1.4
1.6
0.64
1.06
mg/l
—
7
13
12
25
4.81
4.18
1.4
1.6
3.52
6.05
mg/l
—
7
14
12
25
4.81
4.18
1.4
1.6
1.73
2.80
mg/l
—
7
13
12
25
4.81
4.18
1.4
1.6
0.88
0.69
mg/l
—
7
11
27
115
2.36
4.15
1.4
1.3
—
—
—
0
0
30
136
2.22
4.01
1.4
1.6
—
—
—
0
0
14
36
3.90
3.99
1.0
1.0
—
—
—
0
0
145
1030
1.42
3.98
3.3
3.2
25.81
25.30
mmol/l
1.21
137
995
130
905
1.45
3.98
5.0
6.2
0.88
0.90
%
0.40
122
841
262
2045
1.30
3.94
5.0
3.6
5.87
5.85
kpa
0.09
252
1981
39
198
1.98
3.91
1.2
1.6
5.33
5.83
u/l
0.40
32
167
260
2032
1.30
3.88
4.9
3.7
2.08
1.89
mmol/l
0.44
231
1701
27
119
2.28
3.87
1.4
1.3
—
—
—
0
0
92
600
1.55
3.86
3.3
5.8
278.50
551.47
iu/ml
—
6
74
128
897
1.44
3.80
4.9
3.3
25.18
24.78
mmol/l
1.01
122
834
93
611
1.54
3.78
1.4
1.3
—
—
—
0
0
137
973
1.42
3.78
1.5
1.9
1.37
1.48
g/l
0.84
118
845
498
4209
1.21
3.75
2.3
2.3
13.68
14.10
umol/l
0.60
461
3934
226
2902
0.76
3.74
1.4
1.5
—
—
—
0
0
106
1535
0.68
3.74
1.6
1.7
4.69
4.33
mg/l
0.12
72
1110
62
371
1.68
3.70
1.3
1.4
—
—
—
0
0
83
535
1.56
3.68
2.4
3.2
31.14
34.40
umol/l
0.79
78
499
303
2432
1.27
3.68
2.4
2.3
0.22
0.22
g/l
0.14
288
2291
792
6991
1.17
3.62
2.2
2.2
2.85
2.81
mg/l
0.21
682
6033
12
30
4.01
3.59
1.0
1.2
—
—
—
0
0
67
1056
0.63
3.57
1.4
1.5
—
—
—
0
0
250
1970
1.29
3.53
7.1
8.1
6.90
8.26
mmol/l
4.26
238
1893
89
589
1.52
3.53
1.1
1.2
2.00
3.62
u/ml
1.35
26
195
367
3029
1.23
3.50
2.0
2.1
353.97
372.51
nmol/l
1.16
335
2806
43
236
1.83
3.47
1.3
1.2
53.80
50.45
u/ml
—
5
17
339
2783
1.24
3.40
2.6
2.4
34.45
54.23
u/l
0.58
284
2407
82
541
1.53
3.32
1.3
2.0
4.38
5.19
mmol/24h
2.01
75
489
148
1092
1.37
3.31
1.3
1.3
—
—
—
0
0
66
415
1.60
3.29
1.1
1.1
1.48
1.49
g/l
0.05
59
378
51
300
1.71
3.28
1.8
2.0
23.82
21.62
mg/l
0.13
17
79
84
1237
0.67
3.27
1.5
1.7
—
—
—
0
0
195
1504
1.31
3.25
1.6
1.5
—
—
—
0
0
652
5715
1.17
3.24
2.5
2.8
764.53
915.87
ng/l
0.85
549
4723
13
338
0.38
3.22
1.3
1.3
32.02
32.64
nmol/l
0.03
13
296
450
3824
1.20
3.21
2.3
2.3
2.43
2.41
g/l
0.29
413
3546
54
327
1.66
3.14
1.4
1.6
—
—
—
0
0
38
208
1.84
3.12
1.1
1.2
—
—
—
0
0
41
230
1.79
3.11
1.1
1.1
—
—
—
0
0
73
477
1.54
3.11
2.4
2.3
16.89
16.76
%
0.10
35
236
70
456
1.55
3.03
1.7
1.7
—
—
—
0
0
50
302
1.66
2.95
1.3
1.6
—
—
—
0
0
709
7938
0.87
2.90
3.7
3.2
7.78
7.79
mmol/l
0.01
608
6902
208
1649
1.28
2.85
4.9
3.0
5.08
4.68
kpa
1.35
197
1589
47
759
0.61
2.85
1.0
1.1
1.25
1.42
u/ml
0.06
20
366
374
3163
1.20
2.83
3.9
3.8
31.16
31.81
%
0.58
282
2307
21
96
2.19
2.83
1.4
1.3
—
—
—
0
0
21
96
2.19
2.83
1.4
1.3
—
—
—
0
0
11
34
3.24
2.72
1.0
1.1
5.05
82.72
ug/l
—
6
14
308
2568
1.22
2.71
8.4
8.2
1.25
1.01
mmol/l
0.49
241
2023
25
125
2.01
2.70
1.1
1.2
98.29
94.62
%
—
7
52
26
132
1.98
2.70
1.1
1.1
89.75
93.00
%
—
8
55
30
161
1.87
2.66
1.3
1.5
138.73
132.26
nmol/l
0.25
30
161
307
2569
1.21
2.61
8.5
8.2
5.02
5.08
kpa
0.56
291
2456
307
2569
1.21
2.61
8.4
8.2
12.60
12.92
kpa
0.46
292
2458
409
3516
1.18
2.59
2.4
2.4
23.02
23.83
%
0.49
343
3032
41
666
0.61
2.58
1.0
1.1
1.74
3.00
u/ml
0.70
19
312
41
665
0.61
2.56
1.1
1.2
—
—
—
0
0
611
6849
0.87
2.52
3.8
3.3
849.62
395.27
mg/l
0.86
395
4350
642
7169
0.87
2.50
4.3
3.8
9.41
9.23
mg/mmol
0.02
404
4583
361
3081
1.19
2.49
6.7
5.6
—
—
—
0
0
48
302
1.60
2.47
1.3
1.4
—
—
—
0
0
874
7964
1.13
2.46
1.3
1.3
1.00
1.52
u/ml
1.12
212
2282
817
7416
1.13
2.45
1.6
1.5
—
—
—
0
0
62
908
0.68
2.43
1.1
1.1
1.41
2.18
u/ml
0.42
26
454
81
572
1.43
2.43
3.4
3.4
36.16
62.84
mg/l
1.14
69
460
81
572
1.43
2.43
3.3
3.4
27.44
37.54
mg/l
0.83
69
461
150
1911
0.78
2.43
1.4
1.4
—
—
—
0
0
79
556
1.43
2.41
2.8
3.0
25.27
24.59
mmol/l
0.79
79
550
163
2051
0.79
2.39
1.3
1.4
—
—
—
0
0
126
960
1.32
2.38
2.2
2.5
158.14
175.16
%
1.59
119
909
2644
27265
0.90
2.37
4.6
4.7
37.80
38.40
mmol/mol
2.80
2452
25736
41
251
1.64
2.36
1.3
1.5
12.57
11.23
umol/l
0.60
41
235
40
244
1.65
2.34
1.2
1.3
242.86
221.18
titre
—
7
51
33
191
1.73
2.33
4.2
2.9
38427.27
40213.00
ug/l
0.49
33
191
51
331
1.55
2.32
1.3
1.4
—
—
—
0
0
23
119
1.94
2.30
1.6
1.6
—
—
—
0
0
33
192
1.73
2.29
3.2
1.8
2.31
1.72
u/field
0.30
16
98
51
332
1.54
2.29
1.3
1.4
—
—
—
0
0
51
332
1.54
2.29
1.3
1.4
—
—
—
0
0
30
170
1.77
2.28
1.4
1.6
—
—
—
0
0
51
333
1.54
2.27
1.3
1.4
—
—
—
0
0
245
2040
1.22
2.23
9.8
7.4
1.21
1.33
mmol/l
1.22
237
1989
51
335
1.53
2.21
1.3
1.4
—
—
—
0
0
270
2276
1.20
2.17
8.9
8.7
95.77
96.03
%
0.23
260
2194
67
469
1.44
2.14
1.4
1.6
—
—
—
0
0
9
30
3.00
2.14
2.0
2.5
0.67
0.87
u/field
—
9
30
5
152
0.33
2.13
3.0
3.1
5.26
7.67
mg/l
—
5
120
44
283
1.56
2.11
1.3
1.1
—
—
—
0
0
44
283
1.56
2.11
1.3
1.1
—
—
—
0
0
44
283
1.56
2.11
1.3
1.1
—
—
—
0
0
51
340
1.51
2.09
1.3
1.4
—
—
—
0
0
7
20
3.50
2.05
1.0
1.1
8.14
21.70
u/l
—
7
20
121
939
1.30
2.05
2.1
2.0
7.08
4.14
iu/l
1.38
47
365
6
15
4.00
2.04
1.2
1.1
—
—
—
0
0
153
1225
1.26
2.02
10.8
11.4
—
—
—
0
0
22
118
1.87
2.01
1.6
1.6
—
—
—
0
0
5
144
0.35
2.01
3.0
2.5
—
107.07
—
0
20
43
279
1.55
2.00
1.3
1.1
—
—
—
0
0
43
279
1.55
2.00
1.3
1.1
—
—
—
0
0
77
562
1.38
1.97
3.4
3.3
1.18
1.55
ratio
—
7
54
41
620
0.66
1.95
1.0
1.1
2.49
3.44
u/ml
0.28
13
251
5
11
4.55
1.94
2.2
1.1
—
—
—
0
0
55
783
0.70
1.92
1.0
1.1
0.13
1.14
u/ml
3.52
14
335
63
447
1.42
1.91
1.7
1.6
—
—
—
0
0
253
2151
1.19
1.88
9.5
9.0
123.26
123.07
g/l
0.06
245
2092
121
951
1.28
1.88
4.8
3.6
50.21
50.11
%
0.01
116
939
80
593
1.36
1.88
1.5
1.6
—
—
—
0
0
6
17
3.53
1.83
1.0
1.3
—
—
—
0
0
136
1686
0.80
1.82
1.4
1.5
—
—
—
0
0
195
2329
0.83
1.82
3.8
4.0
5.10
38.71
ug/l
1.44
150
1788
26
153
1.70
1.79
1.4
1.4
15.75
20.79
u/ml
—
8
29
113
1427
0.79
1.78
2.0
2.0
—
—
—
0
0
16
81
1.98
1.74
1.3
1.9
9.29
48.10
u/l
1.14
11
75
14
268
0.52
1.69
1.0
1.2
0.03
1.28
u/ml
—
8
129
60
820
0.73
1.68
1.0
1.1
4.59
5.69
u/ml
0.22
29
437
7
25
2.80
1.65
2.0
2.3
—
—
—
0
0
50
351
1.43
1.64
1.4
1.4
283.59
353.91
pmol/l
0.72
44
313
526
5788
0.89
1.62
1.2
1.3
3.50
9.27
u/ml
4.57
207
2453
104
820
1.28
1.62
1.3
1.4
27.00
24.91
u/l
0.28
78
689
127
1562
0.81
1.61
1.3
1.4
—
—
—
0
0
64
472
1.36
1.59
2.7
2.7
8.52
8.44
kpa
0.15
64
465
127
1559
0.81
1.59
1.3
1.4
—
—
—
0
0
111
1383
0.80
1.59
1.4
1.5
—
—
—
0
0
128
1567
0.81
1.56
1.3
1.4
—
—
—
0
0
128
1565
0.81
1.55
1.3
1.4
—
—
—
0
0
40
273
1.47
1.53
1.2
1.7
—
—
—
0
0
78
600
1.31
1.49
1.4
1.6
—
—
—
0
0
39
559
0.69
1.48
2.0
2.5
71.44
106.55
ug/min
0.36
25
346
503
4576
1.11
1.47
2.5
2.7
2.44
2.43
mmol/l
0.57
426
4024
62
818
0.75
1.42
1.4
1.4
0.43
0.45
nmol/l
0.06
47
664
1601
15355
1.07
1.40
2.9
2.9
103.37
91.58
ug/l
1.19
1512
14500
26
165
1.58
1.40
1.3
1.5
27830.08
64894.86
e6/l
0.45
13
93
23
142
1.62
1.38
2.8
2.4
60.52
49.55
umol/l
1.10
23
122
211
1822
1.17
1.38
3.6
3.6
74.73
79.31
ng/l
0.35
183
1626
38
265
1.44
1.34
1.4
1.5
276.25
281.11
mosm/kgh2o
0.33
28
211
77
602
1.28
1.33
1.2
1.4
—
—
—
0
0
39
275
1.42
1.30
1.2
1.2
46.62
58.66
u/l
1.18
34
253
6
24
2.50
1.30
1.0
1.0
—
—
—
0
0
2425
24851
0.93
1.30
3.4
3.5
—
—
—
0
0
14
76
1.85
1.29
1.1
1.1
—
—
—
0
0
41
293
1.40
1.28
1.0
1.1
—
—
—
0
0
15
84
1.79
1.27
3.1
2.1
11.69
16.22
umol/l
1.06
15
84
36
255
1.42
1.19
1.6
1.8
—
—
—
0
0
35
247
1.42
1.18
1.2
1.1
1.06
1.04
ratio
0.49
13
90
6
26
2.31
1.18
1.3
1.2
—
9.64
—
0
8
28
189
1.49
1.18
1.3
1.4
36858.68
3026.73
e6/l
0.46
19
129
17
102
1.67
1.16
1.2
1.2
35.47
10.88
u/l
0.51
17
93
0
35
0.00
1.15
0.0
2.1
—
65.73
—
0
30
2904
29520
0.93
1.15
3.8
3.8
5.68
5.75
mmol/l
2.30
2671
27543
7
31
2.26
1.10
2.0
2.1
—
—
—
0
0
17
104
1.64
1.09
2.9
2.4
—
—
—
0
0
26
177
1.47
1.07
1.1
1.4
5.45
6.32
mmol/l
0.98
26
162
13
74
1.76
1.06
2.7
4.6
—
—
—
0
0
58
453
1.28
1.06
4.2
5.7
384.83
370.63
umol/l
0.28
47
395
683
7268
0.93
1.06
2.2
2.3
2272.35
3558.43
umol/l
0.70
602
6553
5
22
2.27
1.03
1.0
1.1
—
—
—
0
0
54
420
1.29
1.03
1.3
1.2
—
—
—
0
0
43
324
1.33
1.02
1.5
1.6
—
—
—
0
0
35
256
1.37
1.00
1.3
1.1
—
—
—
0
0
17
107
1.59
0.99
1.2
1.3
—
—
—
0
0
723
7656
0.93
0.98
1.5
1.6
1.39
1.40
mmol/l
0.11
601
6619
41
309
1.33
0.98
8.4
6.7
10.75
11.07
mg/l
0.18
35
283
10
54
1.85
0.96
1.1
1.2
—
—
—
0
0
17
108
1.58
0.96
3.6
3.2
—
—
—
0
0
19
126
1.51
0.91
1.3
1.2
—
—
—
0
0
480
4475
1.08
0.90
2.1
2.4
121.56
107.31
ug/g
0.30
355
3590
243
2687
0.90
0.89
1.3
1.3
29.10
26.64
iu/l
0.52
221
2324
262
2378
1.11
0.88
3.3
3.3
4.45
4.53
pmol/l
0.71
230
2131
53
422
1.26
0.87
1.5
1.7
—
—
—
0
0
159
1402
1.14
0.87
6.7
7.8
24.48
24.39
mmol/l
0.12
150
1328
121
1046
1.16
0.86
1.1
1.1
1.24
4.32
u/ml
2.51
13
157
31
231
1.34
0.82
1.2
2.0
—
—
—
0
0
6
32
1.88
0.81
1.2
1.1
—
—
—
0
0
64
774
0.82
0.81
1.2
1.3
2.58
3.71
ug/l
1.54
58
709
32
241
1.33
0.80
3.6
2.3
—
—
—
0
0
68
815
0.83
0.79
3.0
3.6
514.52
1681.44
u/ml
0.42
58
692
58
474
1.23
0.78
1.4
1.3
—
—
—
0
0
14
90
1.56
0.78
1.1
1.1
—
—
—
0
0
264
2428
1.09
0.71
1.2
1.3
131.73
185.75
u/ml
0.97
243
2257
45
362
1.25
0.71
1.1
1.2
—
—
—
0
0
56
463
1.21
0.70
1.3
1.1
—
—
—
0
0
270
2924
0.92
0.69
2.6
2.7
0.61
0.70
ug/l
1.59
179
1719
70
592
1.19
0.69
1.0
1.1
—
—
—
0
0
526
4995
1.06
0.63
3.7
4.1
1.61
2.00
ug/l
2.44
470
4530
15
211
0.71
0.62
1.0
1.1
—
—
—
0
0
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
18
132
1.37
0.57
1.2
1.0
815.08
749.85
ng/l
0.21
12
85
18
132
1.37
0.57
1.2
1.0
205.58
301.16
ng/l
1.96
12
88
6
36
1.67
0.56
1.0
1.0
—
—
—
0
0
6
37
1.62
0.55
1.0
1.0
—
—
—
0
0
10
65
1.54
0.55
1.0
1.2
—
—
—
0
0
57
666
0.85
0.55
2.1
2.2
4.38
5.07
umol/l
0.45
44
480
60
516
1.17
0.53
6.7
8.8
105.25
105.53
mmol/l
0.12
55
458
18
134
1.34
0.53
1.2
1.0
25.71
44.05
ng/l
2.69
12
86
1403
14347
0.96
0.50
2.5
2.4
—
—
—
0
0
51
436
1.17
0.49
1.4
1.6
—
—
—
0
0
51
436
1.17
0.49
1.4
1.6
—
—
—
0
0
50
581
0.86
0.47
2.5
2.4
0.87
0.84
nmol/l
0.07
38
500
178
1649
1.08
0.47
2.2
2.9
97.84
147.63
ng/l
2.71
152
1469
11
154
0.71
0.47
1.5
2.3
26.08
346.93
ug/l
0.95
11
141
14
188
0.74
0.46
1.1
1.4
142.22
213.81
pmol/l
0.65
14
188
192
1787
1.08
0.45
1.8
2.2
12.45
11.98
nmol/l
0.31
173
1623
66
581
1.14
0.45
5.6
3.3
24.09
22.40
mg/l
0.11
36
359
25
308
0.81
0.44
1.8
1.5
—
—
—
0
0
66
746
0.88
0.44
1.9
3.3
1.31
1.39
mg/l
0.31
58
703
65
573
1.14
0.44
1.1
1.1
—
—
—
0
0
28
229
1.22
0.43
1.2
1.3
—
—
—
0
0
32
382
0.84
0.42
1.3
1.5
—
—
—
0
0
19
149
1.28
0.41
1.1
1.4
126.58
159.62
mmol/24h
1.05
19
149
8
60
1.33
0.40
1.5
1.5
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
8.08
—
0
18
66
739
0.89
0.39
1.2
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.4
—
4833.71
—
0
14
42
363
1.16
0.38
1.3
1.2
—
31.57
—
0
7
5
36
1.39
0.38
1.0
1.9
—
—
—
0
0
5
37
1.35
0.37
1.0
1.1
1.31
1.69
umol/24h
—
5
37
9
71
1.27
0.36
1.0
1.0
—
—
—
0
0
35
300
1.17
0.36
1.4
1.6
—
—
—
0
0
35
300
1.17
0.36
1.4
1.6
—
—
—
0
0
59
526
1.12
0.36
2.5
2.1
130.86
131.48
g/l
0.07
50
386
301
2873
1.05
0.35
1.3
1.2
162.90
162.04
iu/ml
0.01
126
1109
14
108
1.30
0.35
1.4
1.2
—
—
—
0
0
9
123
0.73
0.35
1.1
1.0
—
—
—
0
0
6
43
1.40
0.35
1.0
1.4
61.83
102.43
ng/l
—
6
43
31
264
1.18
0.34
3.0
2.2
32.65
32.01
pg
0.54
31
264
166
1764
0.94
0.33
1.7
1.6
341.98
292.72
mu/l
0.82
150
1567
66
602
1.10
0.29
1.1
1.0
1.31
3.45
u/ml
2.75
25
312
19
227
0.84
0.28
1.5
1.3
67.32
73.84
umol/l
1.08
19
227
33
290
1.14
0.27
1.1
1.1
—
—
—
0
0
41
366
1.12
0.26
1.1
1.2
14.94
35.89
u/l
1.77
36
317
209
1997
1.05
0.26
1.1
1.1
—
—
—
0
0
14
113
1.24
0.26
1.1
1.6
—
—
—
0
0
14
113
1.24
0.26
1.1
1.6
—
—
—
0
0
22
255
0.86
0.24
1.5
1.3
1.51
1.57
g/l
0.64
22
255
25
286
0.87
0.23
1.6
1.5
0.87
0.96
g/l
0.63
25
286
19
221
0.86
0.22
3.2
2.6
—
—
—
0
0
10
79
1.27
0.22
1.8
3.4
—
—
—
0
0
10
79
1.27
0.22
1.8
3.4
—
—
—
0
0
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
2.7
—
—
—
0
0
0
10
0.00
0.21
0.0
12.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
49
533
0.92
0.21
1.1
1.1
3.89
16685.75
iu/ml
0.56
14
145
72
769
0.94
0.20
1.8
1.6
—
—
—
0
0
78
732
1.07
0.20
1.2
1.2
293.64
268.16
u/ml
0.23
47
486
6
49
1.22
0.20
1.0
1.3
—
—
—
0
0
72
674
1.07
0.20
1.2
1.4
165.39
109.69
u/ml
0.44
14
148
6
50
1.20
0.19
1.3
1.3
—
—
—
0
0
82
772
1.06
0.19
1.2
1.2
—
—
—
0
0
16
137
1.17
0.18
1.4
1.7
—
—
—
0
0
16
137
1.17
0.18
1.4
1.7
—
—
—
0
0
14
119
1.18
0.17
1.3
1.4
71.50
100.65
nmol/24h
1.16
14
119
440
4489
0.98
0.16
1.8
1.8
1.48
1.39
%
1.88
401
4025
20
225
0.89
0.16
1.6
1.5
28.85
34.50
%
0.36
13
135
35
380
0.92
0.15
2.5
2.8
8.01
77.68
u/ml
0.93
35
374
363
3706
0.98
0.15
1.9
1.8
—
—
—
0
0
50
532
0.94
0.14
1.2
1.2
—
—
—
0
0
12
139
0.86
0.14
1.2
1.1
—
—
—
0
0
17
191
0.89
0.13
1.5
1.6
—
—
—
0
0
92
959
0.96
0.13
1.2
1.1
—
—
—
0
0
692
7007
0.98
0.13
2.3
2.1
—
—
—
0
0
34
317
1.07
0.12
1.2
1.4
8.57
8.15
mmol/l
0.27
34
312
60
572
1.05
0.11
1.6
1.8
226.44
197.12
pmol/l
1.01
55
536
182
1777
1.03
0.11
2.0
2.1
6.02
6.86
ug/l
0.37
154
1579
219
2237
0.98
0.11
1.9
2.4
78.19
73.41
ml/min/173m2
1.14
91
837
36
383
0.94
0.10
3.9
4.4
19.44
71.19
u/ml
—
8
110
390
3958
0.98
0.10
3.3
3.6
21.19
21.16
%
0.01
158
1610
65
678
0.96
0.10
1.8
1.8
—
—
—
0
0
23
249
0.92
0.10
2.0
1.7
—
—
—
0
0
5
44
1.14
0.10
1.2
1.6
—
—
—
0
0
5
45
1.11
0.09
1.0
1.3
—
—
—
0
0
58
605
0.96
0.09
1.4
1.7
8796.28
9743.18
e6/l
0.10
39
438
119
1223
0.97
0.09
1.8
1.8
—
—
—
0
0
79
763
1.04
0.09
1.5
1.4
290.21
299.46
ug/g
0.13
39
396
172
1683
1.02
0.09
1.5
1.5
—
—
—
0
0
5
64
0.78
0.08
1.0
1.2
—
—
—
0
0
20
185
1.08
0.08
2.0
1.8
—
—
—
0
0
94
966
0.97
0.08
1.2
1.1
—
—
—
0
0
24
225
1.07
0.07
1.3
1.6
—
—
—
0
0
24
225
1.07
0.07
1.3
1.6
—
—
—
0
0
24
225
1.07
0.07
1.3
1.6
—
—
—
0
0
167
1640
1.02
0.07
1.4
1.5
—
—
—
0
0
545
5403
1.01
0.07
1.9
2.0
—
—
—
0
0
68
659
1.03
0.07
1.2
1.4
—
—
—
0
0
9
87
1.03
0.07
2.0
1.7
—
—
—
0
0
797
7920
1.01
0.06
1.6
1.6
—
—
—
0
0
119
1214
0.98
0.06
1.2
1.3
11.70
10.60
u/l
0.37
98
1012
24
227
1.06
0.06
1.2
1.2
—
—
—
0
0
22
208
1.06
0.05
3.3
3.7
—
—
—
0
0
604
6076
0.99
0.05
1.3
1.3
16.25
26.92
iu/ml
2.64
144
1986
19
181
1.05
0.03
1.7
1.8
—
—
—
0
0
10
92
1.09
0.03
1.1
1.2
—
—
—
0
0
18
189
0.95
0.03
2.2
1.3
—
—
—
0
0
284
2857
0.99
0.02
1.8
1.8
—
—
—
0
0
12
128
0.94
0.02
1.0
1.0
—
—
—
0
0
194
1953
0.99
0.02
1.9
2.8
24.95
42.64
u/ml
2.55
188
1892
27
262
1.03
0.02
1.3
1.1
—
—
—
0
0
12
113
1.06
0.01
1.5
1.8
—
—
—
0
0
12
113
1.06
0.01
1.5
1.8
—
—
—
0
0
606
6075
1.00
0.01
2.0
2.1
—
—
—
0
0
11
104
1.06
0.01
2.0
1.5
9.04
8.14
ug/l
0.25
11
104
13
124
1.05
0.00
1.1
1.2
—
—
—
0
0
25
256
0.98
0.00
2.4
1.6
1.18
1.28
promille
0.12
20
206
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
67
664
1.01
0.00
6.8
3.7
0.42
0.34
u/ml
0.65
36
371
23
228
1.01
0.00
1.2
1.4
20330.29
59815.74
e6/l
0.66
17
157
24
242
0.99
0.00
1.2
1.2
—
—
—
0
0
30
302
0.99
0.00
1.6
1.6
48.18
57.60
%
0.61
22
184
16
155
1.03
0.00
1.5
2.8
276.71
183.28
umol/l
—
7
83
24
239
1.00
0.00
1.2
1.2
—
—
—
0
0
25
249
1.00
0.00
1.3
1.5
—
—
—
0
0
11
114
0.96
0.00
1.5
1.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
1033.44
—
0
9
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.0
—
—
—
0
0
32
320
1.00
-0.00
1.1
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
28.33
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: G6_DEMYEL – Demyelinating diseases of the central nervous system
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).